MEDITREE HEALTHCARE INTERNATIONAL LIMITED

Company Registration Number:
SC755719 (Scotland)

Unaudited abridged accounts for the year ended 31 January 2024

Period of accounts

Start date: 17 January 2023

End date: 31 January 2024

MEDITREE HEALTHCARE INTERNATIONAL LIMITED

Contents of the Financial Statements

for the Period Ended 31 January 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

MEDITREE HEALTHCARE INTERNATIONAL LIMITED

Company Information

for the Period Ended 31 January 2024




Director: Andrew Enumah
Raphael Komla Gbedebu
Registered office: 2/3
48 West George Street
Glasgow
GB-SCT
G2 1BP
Company Registration Number: SC755719 (Scotland)

MEDITREE HEALTHCARE INTERNATIONAL LIMITED

Balance sheet

As at 31 January 2024


Notes

2024
£
Fixed assets
Tangible assets: 5 4,645
Total fixed assets: 4,645
Current assets
Cash at bank and in hand: 1,359
Total current assets: 1,359
Creditors: amounts falling due within one year: 6 ( 11,276 )
Net current assets (liabilities): ( 9,917 )
Total assets less current liabilities: ( 5,272 )
Total net assets (liabilities): ( 5,272 )

The notes form part of these financial statements

MEDITREE HEALTHCARE INTERNATIONAL LIMITED

Balance sheet continued

As at 31 January 2024


Notes

2024
£
Capital and reserves
Called up share capital: 3
Revaluation reserve: 7 248
Profit and loss account: ( 5,523 )
Shareholders funds: ( 5,272 )

For the year ending 31 January 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 12 October 2024
And Signed On Behalf Of The Board By:

Name: Andrew Enumah
Status: Director

The notes form part of these financial statements

MEDITREE HEALTHCARE INTERNATIONAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MEDITREE HEALTHCARE INTERNATIONAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 2. Employees


    2024
    Average number of employees during the period 4

MEDITREE HEALTHCARE INTERNATIONAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 3. Off balance sheet disclosure

    No

MEDITREE HEALTHCARE INTERNATIONAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2024

5. Tangible Assets

Total
Cost £
Additions 4,645
Disposals -
Revaluations -
Transfers -
At 31 January 2024 4,645
Depreciation
Charge for year -
On disposals -
Other adjustments -
At 31 January 2024 -
Net book value
At 31 January 2024 4,645

MEDITREE HEALTHCARE INTERNATIONAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2024

6. Creditors: amounts falling due within one year note

The directors have provided funding as an indication of their willingness and ability to support the company inorder for it to meet its capital requirements and associated initial business setup costs.

MEDITREE HEALTHCARE INTERNATIONAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2024

7. Revaluation reserve


2024
£
Surplus or deficit after revaluation 248
Balance at 31 January 2024 248